Boehringer Ingelheim (Japan)
Alternate name 日本ベーリンガーインゲルハイム株式会社
Parent institution Boehringer Ingelheim (Germany)
ROR: Yes
Works count: 505
Citations count: 11,930
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications
2011 · Yohei Kawabata, Koichi Wada, et al. · International Journal of Pharmaceutics
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition
2020 · Issei Tomita, Shinji Kume, et al. · Cell Metabolism
Dietary Linoleic Acid Elevates Endogenous 2‐AG and Anandamide and Induces Obesity
2012 · Anita Røyneberg Alvheim, Marian Kjellevold, et al. · Obesity